Northern Technologies (NTIC) Q3 2024 Earnings Report

Revenue and mix: Consolidated net sales declined 1.4% YoY to $20.7 million in Q3 2024, while joint-venture sales decreased 2.7% YoY to $25.6 million. China subsidiary sales rose 6.7% YoY to $3.5 million, signaling stabilizing demand in a strategically important market. Product-line highlights include Natur-Tec bioplastics up 20.1% YoY to a quarterly record of $5.8 million; ZERUST Oil & Gas down 31.9% YoY to $1.4 million due to a ~$0.6 million shipment delay into Q4, which management expects to lift Q4 performance. Margin and profitability: Gross margin improved 210 basis points YoY to 38.2% (vs. 36.1% in the prior year), aided by insourcing and higher-margin resin products. Operating margin stood at 7.37% (vs. 4.01% prior year magnitude), with operating income of $1.523 million. Net income was $0.977 million ($0.10 per diluted share), vs. $1.10 million ($0.11) one year ago. Efficiency and cost: Total operating expenses rose 7.1% to $9.0 million, driven by personnel costs, with operating expenses as a percentage of net sales at 43.4% (vs. 40.0% prior year). Cash and liquidity: Net cash provided by operating activities for the nine months ended May 31, 2024 was $7.6 million, and as of May 31, 2024 NTIC carried $4.8 million debt with $5.8 million in cash, yielding a net debt position of approximately -$0.74 million. Capital allocation: Free cash flow for the period stood at $0.846 million; dividends of $0.07 per share were paid in Q3. Balance sheet: Total assets of $89.3 million and total stockholders’ equity of $68.85 million; total liabilities of $16.69 million. Long-term growth indicators: Natur-Tec expansion in India (single facility consolidation and capacity expansion), Brazil, and Circle Pines insourcing to lift gross margin; China growth potential remains a long-run cornerstone. YoY and QoQ earnings metrics show positive trajectory in key operating metrics, though near-term timing in Oil & Gas remains a driver of quarterly volatility.